Skip to main content
. 2017 Aug 1;43(3):289–296. doi: 10.5152/tud.2017.35467

Table 2.

Mean total, free and bioavailable testosterone levels between patients with benign and malign histology

Benign (n=245) Cancer (n=160) p
Total testosterone (ng/dL) 347±124 344±128 0.877
Free testosterone (ng/dL) 6.1±2 5.8±1.9 0.266
Bioavailable testosterone (ng/dL) 148±49 141±47 0.187